{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T09:18:40Z","timestamp":1773911920828,"version":"3.50.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T00:00:00Z","timestamp":1587600000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T00:00:00Z","timestamp":1587600000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17K01470"],"award-info":[{"award-number":["17K01470"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Advanced glycation end products (AGEs) are associated with aging, diabetes mellitus (DM), and other chronic diseases. Recently, the accumulation of AGEs can be evaluated by skin autofluorescence (SAF). However, the relationship between SAF levels and exercise capacity in patients with cardiovascular disease (CVD) remains unclear. This study aimed to investigate the association between the tissue accumulation of AGEs and clinical characteristics, including exercise capacity, in patients with CVD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We enrolled 319 consecutive CVD patients aged \u226540\u2009years who underwent early phase II cardiac rehabilitation (CR) at our university hospital between November 2015 and September 2017. Patient background, clinical data, and the accumulation of AGEs assessed by SAF were recorded at the beginning of CR. Characteristics were compared between two patient groups divided according to the median SAF level (High SAF and Low SAF).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The High SAF group was significantly older and exhibited a higher prevalence of DM than the Low SAF group. The sex ratio did not differ between the two groups. AGE levels showed significant negative correlations with peak oxygen uptake and ventilator efficiency (both <jats:italic>P<\/jats:italic>\u2009&lt;\u2009\u00a00.0001). Exercise capacity was significantly lower in the high SAF group than in the low SAF group, regardless of the presence or absence of DM (<jats:italic>P<\/jats:italic>\u2009&lt;\u2009\u00a00.05). A multivariate logistic regression analysis showed that SAF level was an independent factor associated with reduced exercise capacity (odds ratio 2.10; 95% confidence interval 1.13\u20134.05; <jats:italic>P<\/jats:italic>\u2009=\u20090.02).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>High levels of tissue accumulated AGEs, as assessed by SAF, were significantly and independently associated with reduced exercise capacity. These data suggest that measuring the tissue accumulation of AGEs may be useful in patients who have undergone CR, irrespective of whether they have DM.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12872-020-01484-3","type":"journal-article","created":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T04:02:46Z","timestamp":1587614566000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Association between the tissue accumulation of advanced glycation end products and exercise capacity in cardiac rehabilitation patients"],"prefix":"10.1186","volume":"20","author":[{"given":"Mitsuhiro","family":"Kunimoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunori","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miho","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomomi","family":"Matsubara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuro","family":"Aikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shohei","family":"Ouchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megumi","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosuke","family":"Fukao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuro","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyasu","family":"Kadoguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abidan","family":"Abulimiti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akio","family":"Honzawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miki","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akie","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taira","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tohru","family":"Asai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Amano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andries J.","family":"Smit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Daida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,4,23]]},"reference":[{"issue":"2","key":"1484_CR1","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/0735-1097(94)90420-0","volume":"23","author":"L Vanhees","year":"1994","unstructured":"Vanhees L, Fagard R, Thijs L, Staessen J, Amery A. Prognostic significance of peak exercise capacity in patients with coronary artery disease. J Am Coll Cardiol. 1994;23(2):358\u201363.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"1484_CR2","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.jvs.2012.07.051","volume":"57","author":"NJ Leeper","year":"2013","unstructured":"Leeper NJ, Myers J, Zhou M, Nead KT, Syed A, Kojima Y, et al. Exercise capacity is the strongest predictor of mortality in patients with peripheral arterial disease. J Vasc Surg. 2013;57(3):728\u201333.","journal-title":"J Vasc Surg"},{"issue":"11","key":"1484_CR3","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1056\/NEJMoa011858","volume":"346","author":"J Myers","year":"2002","unstructured":"Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med. 2002;346(11):793\u2013801.","journal-title":"N Engl J Med"},{"issue":"3","key":"1484_CR4","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1161\/01.CIR.83.3.778","volume":"83","author":"DM Mancini","year":"1991","unstructured":"Mancini DM, Eisen H, Kussmaul W, Mull R, Edmunds LH Jr, Wilson JR. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation. 1991;83(3):778\u201386.","journal-title":"Circulation."},{"issue":"24","key":"1484_CR5","doi-asserted-by":"publisher","first-page":"3079","DOI":"10.1161\/01.CIR.0000041428.99427.06","volume":"106","author":"AK Gitt","year":"2002","unstructured":"Gitt AK, Wasserman K, Kilkowski C, Kleemann T, Kilkowski A, Bangert M, et al. Exercise anaerobic threshold and ventilatory efficiency identify heart failure patients for high risk of early death. Circulation. 2002;106(24):3079\u201384.","journal-title":"Circulation."},{"issue":"3","key":"1484_CR6","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/S0735-1097(97)00533-0","volume":"31","author":"N Osada","year":"1998","unstructured":"Osada N, Chaitman BR, Miller LW, Yip D, Cishek MB, Wolford TL, et al. Cardiopulmonary exercise testing identifies low risk patients with heart failure and severely impaired exercise capacity considered for heart transplantation. J Am Coll Cardiol. 1998;31(3):577\u201382.","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"1484_CR7","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1016\/S0735-1097(02)01840-5","volume":"39","author":"C Zugck","year":"2002","unstructured":"Zugck C, Haunstetter A, Kruger C, Kell R, Schellberg D, Kubler W, et al. Impact of beta-blocker treatment on the prognostic value of currently used risk predictors in congestive heart failure. J Am Coll Cardiol. 2002;39(10):1615\u201322.","journal-title":"J Am Coll Cardiol"},{"issue":"6865","key":"1484_CR8","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/414813a","volume":"414","author":"M Brownlee","year":"2001","unstructured":"Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414(6865):813\u201320.","journal-title":"Nature."},{"issue":"2","key":"1484_CR9","first-page":"75","volume":"24","author":"K Prasad","year":"2015","unstructured":"Prasad K, Dhar I, Caspar-Bell G. Role of advanced Glycation end products and its receptors in the pathogenesis of cigarette smoke-induced cardiovascular disease. Int J Angiol. 2015;24(2):75\u201380.","journal-title":"Int J Angiol"},{"issue":"1","key":"1484_CR10","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s11892-013-0453-1","volume":"14","author":"H Vlassara","year":"2014","unstructured":"Vlassara H, Uribarri J. Advanced glycation end products (AGE) and diabetes: cause, effect, or both? Curr Diab Rep. 2014;14(1):453.","journal-title":"Curr Diab Rep"},{"issue":"1","key":"1484_CR11","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ecl.2013.09.007","volume":"43","author":"JC Kovacic","year":"2014","unstructured":"Kovacic JC, Castellano JM, Farkouh ME, Fuster V. The relationships between cardiovascular disease and diabetes: focus on pathogenesis. Endocrinol Metab Clin N Am. 2014;43(1):41\u201357.","journal-title":"Endocrinol Metab Clin N Am"},{"issue":"1","key":"1484_CR12","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1093\/gerona\/gln018","volume":"64","author":"M Dalal","year":"2009","unstructured":"Dalal M, Ferrucci L, Sun K, Beck J, Fried LP, Semba RD. Elevated serum advanced glycation end products and poor grip strength in older community-dwelling women. J Gerontol A Biol Sci Med Sci. 2009;64(1):132\u20137.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"1","key":"1484_CR13","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s00421-009-1192-5","volume":"108","author":"RD Semba","year":"2010","unstructured":"Semba RD, Bandinelli S, Sun K, Guralnik JM, Ferrucci L. Relationship of an advanced glycation end product, plasma carboxymethyl-lysine, with slow walking speed in older adults: the InCHIANTI study. Eur J Appl Physiol. 2010;108(1):191\u20135.","journal-title":"Eur J Appl Physiol"},{"key":"1484_CR14","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.ijcard.2015.03.167","volume":"185","author":"S Yamagishi","year":"2015","unstructured":"Yamagishi S, Fukami K, Matsui T. Evaluation of tissue accumulation levels of advanced glycation end products by skin autofluorescence: a novel marker of vascular complications in high-risk patients for cardiovascular disease. Int J Cardiol. 2015;185:263\u20138.","journal-title":"Int J Cardiol"},{"issue":"18","key":"1484_CR15","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.009833","volume":"7","author":"I Cavero-Redondo","year":"2018","unstructured":"Cavero-Redondo I, Soriano-Cano A, Alvarez-Bueno C, Cunha PG, Martinez-Hortelano JA, Garrido-Miguel M, et al. Skin autofluorescence-indicated advanced Glycation end products as predictors of cardiovascular and all-cause mortality in high-risk subjects: a systematic review and meta-analysis. J Am Heart Assoc. 2018;7(18):e009833.","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"1484_CR16","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s00125-018-4769-x","volume":"62","author":"RP van Waateringe","year":"2019","unstructured":"van Waateringe RP, Fokkens BT, Slagter SN, van der Klauw MM, van Vliet-Ostaptchouk JV, Graaff R, et al. Skin autofluorescence predicts incident type 2 diabetes, cardiovascular disease and mortality in the general population. Diabetologia. 2019;62(2):269\u201380.","journal-title":"Diabetologia."},{"issue":"5","key":"1484_CR17","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1111\/ggi.12787","volume":"17","author":"M Kato","year":"2017","unstructured":"Kato M, Kubo A, Sugioka Y, Mitsui R, Fukuhara N, Nihei F, et al. Relationship between advanced glycation end-product accumulation and low skeletal muscle mass in Japanese men and women. Geriatr Gerontol Int. 2017;17(5):785\u201390.","journal-title":"Geriatr Gerontol Int"},{"issue":"7","key":"1484_CR18","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1007\/s00125-004-1451-2","volume":"47","author":"R Meerwaldt","year":"2004","unstructured":"Meerwaldt R, Graaff R, Oomen PHN, Links TP, Jager JJ, Alderson NL, et al. Simple non-invasive assessment of advanced glycation endproduct accumulation. Diabetologia. 2004;47(7):1324\u201330.","journal-title":"Diabetologia."},{"issue":"3","key":"1484_CR19","doi-asserted-by":"publisher","first-page":"259","DOI":"10.4161\/derm.22028","volume":"4","author":"P Gkogkolou","year":"2012","unstructured":"Gkogkolou P, Bohm M. Advanced glycation end products: key players in skin aging? Dermatoendocrinol. 2012;4(3):259\u201370.","journal-title":"Dermatoendocrinol."},{"issue":"12","key":"1484_CR20","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.2337\/dc05-2173","volume":"29","author":"HL Lutgers","year":"2006","unstructured":"Lutgers HL, Graaff R, Links TP, Ubink-Veltmaat LJ, Bilo HJ, Gans RO, et al. Skin autofluorescence as a noninvasive marker of vascular damage in patients with type 2 diabetes. Diabetes Care. 2006;29(12):2654\u20139.","journal-title":"Diabetes Care"},{"issue":"6","key":"1484_CR21","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","volume":"53","author":"S Matsuo","year":"2009","unstructured":"Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53(6):982\u201392.","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"1484_CR22","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jjcc.2012.11.004","volume":"61","author":"M Nishitani","year":"2013","unstructured":"Nishitani M, Shimada K, Masaki M, Sunayama S, Kume A, Fukao K, et al. Effect of cardiac rehabilitation on muscle mass, muscle strength, and exercise tolerance in diabetic patients after coronary artery bypass grafting. J Cardiol. 2013;61(3):216\u201321.","journal-title":"J Cardiol"},{"issue":"1","key":"1484_CR23","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1253\/circj.CJ-18-0738","volume":"83","author":"M Nishitani-Yokoyama","year":"2018","unstructured":"Nishitani-Yokoyama M, Miyauchi K, Shimada K, Yokoyama T, Ouchi S, Aikawa T, et al. Impact of physical activity on coronary plaque volume and components in acute coronary syndrome patients after early phase II cardiac rehabilitation. Circ J. 2018;83(1):101\u20139.","journal-title":"Circ J"},{"issue":"4","key":"1484_CR24","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/ggi.13617","volume":"19","author":"M Kunimoto","year":"2019","unstructured":"Kunimoto M, Shimada K, Yokoyama M, Matsubara T, Aikawa T, Ouchi S, et al. Relationship between the Kihon checklist and the clinical parameters in patients who participated in cardiac rehabilitation. Geriatr Gerontol Int. 2019;19(4):287\u201392.","journal-title":"Geriatr Gerontol Int"},{"issue":"1","key":"1484_CR25","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1093\/eurjhf\/hfq168","volume":"13","author":"S Willemsen","year":"2011","unstructured":"Willemsen S, Hartog JW, Hummel YM, van Ruijven MH, van der Horst IC, van Veldhuisen DJ, et al. Tissue advanced glycation end products are associated with diastolic function and aerobic exercise capacity in diabetic heart failure patients. Eur J Heart Fail. 2011;13(1):76\u201382.","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"1484_CR26","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.2337\/db05-1183","volume":"55","author":"SW Park","year":"2006","unstructured":"Park SW, Goodpaster BH, Strotmeyer ES, de Rekeneire N, Harris TB, Schwartz AV, et al. Decreased muscle strength and quality in older adults with type 2 diabetes: the health, aging, and body composition study. Diabetes. 2006;55(6):1813\u20138.","journal-title":"Diabetes."},{"issue":"2","key":"1484_CR27","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0168-8227(00)00170-4","volume":"50","author":"M Kunitomi","year":"2000","unstructured":"Kunitomi M, Takahashi K, Wada J, Suzuki H, Miyatake N, Ogawa S, et al. Re-evaluation of exercise prescription for Japanese type 2 diabetic patients by ventilatory threshold. Diabetes Res Clin Pract. 2000;50(2):109\u201315.","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"1484_CR28","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jjcc.2011.05.001","volume":"58","author":"M Nishitani","year":"2011","unstructured":"Nishitani M, Shimada K, Sunayama S, Masaki Y, Kume A, Fukao K, et al. Impact of diabetes on muscle mass, muscle strength, and exercise tolerance in patients after coronary artery bypass grafting. J Cardiol. 2011;58(2):173\u201380.","journal-title":"J Cardiol"},{"issue":"1","key":"1484_CR29","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s11154-012-9234-4","volume":"14","author":"JE Reusch","year":"2013","unstructured":"Reusch JE, Bridenstine M, Regensteiner JG. Type 2 diabetes mellitus and exercise impairment. Rev Endocr Metab Disord. 2013;14(1):77\u201386.","journal-title":"Rev Endocr Metab Disord"},{"issue":"10","key":"1484_CR30","doi-asserted-by":"publisher","first-page":"3687","DOI":"10.1210\/jc.2008-2844","volume":"94","author":"KJ Nadeau","year":"2009","unstructured":"Nadeau KJ, Zeitler PS, Bauer TA, Brown MS, Dorosz JL, Draznin B, et al. Insulin resistance in adolescents with type 2 diabetes is associated with impaired exercise capacity. J Clin Endocrinol Metab. 2009;94(10):3687\u201395.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1484_CR31","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1210\/jc.2009-1756","volume":"95","author":"KJ Nadeau","year":"2010","unstructured":"Nadeau KJ, Regensteiner JG, Bauer TA, Brown MS, Dorosz JL, Hull A, et al. Insulin resistance in adolescents with type 1 diabetes and its relationship to cardiovascular function. J Clin Endocrinol Metab. 2010;95(2):513\u201321.","journal-title":"J Clin Endocrinol Metab"},{"key":"1484_CR32","doi-asserted-by":"crossref","unstructured":"Uruska A, Gandecka A, Araszkiewicz A, Zozulinska-Ziolkiewicz D. Accumulation of advanced glycation end products in the skin is accelerated in relation to insulin resistance in people with type 1 diabetes mellitus. Diabet Med. 2019;36(5):620\u20135.","DOI":"10.1111\/dme.13921"},{"issue":"1","key":"1484_CR33","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/j.1755-5922.2010.00177.x","volume":"30","author":"N Tahara","year":"2012","unstructured":"Tahara N, Yamagishi S, Matsui T, Takeuchi M, Nitta Y, Kodama N, et al. Serum levels of advanced glycation end products (AGEs) are independent correlates of insulin resistance in nondiabetic subjects. Cardiovasc Ther. 2012;30(1):42\u20138.","journal-title":"Cardiovasc Ther"},{"issue":"3","key":"1484_CR34","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1177\/1479164112459664","volume":"10","author":"LA Knaub","year":"2013","unstructured":"Knaub LA, McCune S, Chicco AJ, Miller M, Moore RL, Birdsey N, et al. Impaired response to exercise intervention in the vasculature in metabolic syndrome. Diab Vasc Dis Res. 2013;10(3):222\u201338.","journal-title":"Diab Vasc Dis Res"},{"issue":"10","key":"1484_CR35","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s00125-004-1525-1","volume":"47","author":"S Srinivasan","year":"2004","unstructured":"Srinivasan S, Hatley ME, Bolick DT, Palmer LA, Edelstein D, Brownlee M, et al. Hyperglycaemia-induced superoxide production decreases eNOS expression via AP-1 activation in aortic endothelial cells. Diabetologia. 2004;47(10):1727\u201334.","journal-title":"Diabetologia."},{"issue":"4","key":"1484_CR36","doi-asserted-by":"publisher","first-page":"90","DOI":"10.4330\/wjc.v4.i4.90","volume":"4","author":"Z Hegab","year":"2012","unstructured":"Hegab Z, Gibbons S, Neyses L, Mamas MA. Role of advanced glycation end products in cardiovascular disease. World J Cardiol. 2012;4(4):90\u2013102.","journal-title":"World J Cardiol"},{"issue":"4","key":"1484_CR37","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1161\/01.CIR.98.4.369","volume":"98","author":"AJ Maxwell","year":"1998","unstructured":"Maxwell AJ, Schauble E, Bernstein D, Cooke JP. Limb blood flow during exercise is dependent on nitric oxide. Circulation. 1998;98(4):369\u201374.","journal-title":"Circulation."},{"issue":"7","key":"1484_CR38","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.2337\/diacare.28.7.1643","volume":"28","author":"ZY Fang","year":"2005","unstructured":"Fang ZY, Sharman J, Prins JB, Marwick TH. Determinants of exercise capacity in patients with type 2 diabetes. Diabetes Care. 2005;28(7):1643\u20138.","journal-title":"Diabetes Care"},{"issue":"5","key":"1484_CR39","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/0735-1097(91)90832-T","volume":"17","author":"DW Kitzman","year":"1991","unstructured":"Kitzman DW, Higginbotham MB, Cobb FR, Sheikh KH, Sullivan MJ. Exercise intolerance in patients with heart failure and preserved left ventricular systolic function: failure of the frank-Starling mechanism. J Am Coll Cardiol. 1991;17(5):1065\u201372.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"1484_CR40","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1001\/jama.2008.1022","volume":"301","author":"J Grewal","year":"2009","unstructured":"Grewal J, McCully RB, Kane GC, Lam C, Pellikka PA. Left ventricular function and exercise capacity. JAMA. 2009;301(3):286\u201394.","journal-title":"JAMA."},{"issue":"4","key":"1484_CR41","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1002\/clc.22378","volume":"38","author":"R Fontes-Carvalho","year":"2015","unstructured":"Fontes-Carvalho R, Sampaio F, Teixeira M, Rocha-Gon\u00e7alves F, Gama V, Azevedo A, et al. Left ventricular diastolic dysfunction and E\/E' ratio as the strongest echocardiographic predictors of reduced exercise capacity after acute myocardial infarction. Clin Cardiol. 2015;38(4):222\u20139.","journal-title":"Clin Cardiol"},{"issue":"12","key":"1484_CR42","doi-asserted-by":"publisher","first-page":"877","DOI":"10.2165\/00007256-200333120-00002","volume":"33","author":"S Hawkins","year":"2003","unstructured":"Hawkins S, Wiswell R. Rate and mechanism of maximal oxygen consumption decline with aging:implications for exercise training. Sports Med. 2003;33(12):877\u201388.","journal-title":"Sports Med"},{"issue":"8","key":"1484_CR43","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s11892-017-0891-2","volume":"17","author":"C Luevano-Contreras","year":"2017","unstructured":"Luevano-Contreras C, Gomez-Ojeda A, Macias-Cervantes MH, Garay-Sevilla ME. Dietary advanced Glycation end products and Cardiometabolic risk. Curr Diab Rep. 2017;17(8):63.","journal-title":"Curr Diab Rep."},{"issue":"8","key":"1484_CR44","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1093\/eurjhf\/hfr067","volume":"13","author":"JW Hartog","year":"2011","unstructured":"Hartog JW, Willemsen S, van Veldhuisen DJ, Posma JL, van Wijk LM, Hummel YM, et al. Effects of alagebrium, an advanced glycation endproduct breaker, on exercise tolerance and cardiac function in patients with chronic heart failure. Eur J Heart Fail. 2011;13(8):899\u2013908.","journal-title":"Eur J Heart Fail"},{"key":"1484_CR45","doi-asserted-by":"publisher","first-page":"534873","DOI":"10.1155\/2015\/534873","volume":"2015","author":"F Boyer","year":"2015","unstructured":"Boyer F, Vidot JB, Dubourg AG, Rondeau P, Essop MF, Bourdon E. Oxidative stress and adipocyte biology: focus on the role of AGEs. Oxidative Med Cell Longev. 2015;2015:534873.","journal-title":"Oxidative Med Cell Longev"},{"issue":"13","key":"1484_CR46","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1001\/jama.288.13.1622","volume":"288","author":"KJ Stewart","year":"2002","unstructured":"Stewart KJ. Exercise training and the cardiovascular consequences of type 2 diabetes and hypertension: plausible mechanisms for improving cardiovascular health. JAMA. 2002;288(13):1622\u201331.","journal-title":"JAMA."},{"issue":"10","key":"1484_CR47","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.2337\/dc06-2487","volume":"30","author":"PM Ribisl","year":"2007","unstructured":"Ribisl PM, Lang W, Jaramillo SA, Jakicic JM, Stewart KJ, Bahnson J, et al. Exercise capacity and cardiovascular\/metabolic characteristics of overweight and obese individuals with type 2 diabetes: the look AHEAD clinical trial. Diabetes Care. 2007;30(10):2679\u201384.","journal-title":"Diabetes Care"},{"issue":"8","key":"1484_CR48","doi-asserted-by":"publisher","first-page":"605","DOI":"10.7326\/0003-4819-132-8-200004180-00002","volume":"132","author":"M Wei","year":"2000","unstructured":"Wei M, Gibbons LW, Kampert JB, Nichaman MZ, Blair SN. Low cardiorespiratory fitness and physical inactivity as predictors of mortality in men with type 2 diabetes. Ann Intern Med. 2000;132(8):605\u201311.","journal-title":"Ann Intern Med"},{"key":"1484_CR49","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.redox.2017.01.013","volume":"11","author":"S Rovira-Llopis","year":"2017","unstructured":"Rovira-Llopis S, Banuls C, Diaz-Morales N, Hernandez-Mijares A, Rocha M, Victor VM. Mitochondrial dynamics in type 2 diabetes: pathophysiological implications. Redox Biol. 2017;11:637\u201345.","journal-title":"Redox Biol"},{"issue":"14","key":"1484_CR50","doi-asserted-by":"publisher","first-page":"14416","DOI":"10.1364\/OE.18.014416","volume":"18","author":"M Koetsier","year":"2010","unstructured":"Koetsier M, Nur E, Chunmao H, Lutgers HL, Links TP, Smit AJ, et al. Skin color independent assessment of aging using skin autofluorescence. Opt Express. 2010;18(14):14416\u201329.","journal-title":"Opt Express"},{"issue":"5","key":"1484_CR51","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1089\/dia.2006.8.523","volume":"8","author":"DJ Mulder","year":"2006","unstructured":"Mulder DJ, Water TV, Lutgers HL, Graaff R, Gans RO, Zijlstra F, et al. Skin autofluorescence, a novel marker for glycemic and oxidative stress-derived advanced glycation endproducts: an overview of current clinical studies, evidence, and limitations. Diabetes Technol Ther. 2006;8(5):523\u201335.","journal-title":"Diabetes Technol Ther"},{"issue":"2","key":"1484_CR52","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1089\/dia.2010.0123","volume":"13","author":"MJ Noordzij","year":"2011","unstructured":"Noordzij MJ, Lefrandt JD, Graaff R, Smit AJ. Dermal factors influencing measurement of skin autofluorescence. Diabetes Technol Ther. 2011;13(2):165\u201370.","journal-title":"Diabetes Technol Ther"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-020-01484-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-020-01484-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-020-01484-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T23:18:03Z","timestamp":1619133483000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-020-01484-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,23]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1484"],"URL":"https:\/\/doi.org\/10.1186\/s12872-020-01484-3","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,23]]},"assertion":[{"value":"8 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Approval was received from the Juntendo University and authorization for the usage of medical records was obtained. The study protocol was approved by the ethical committee of Juntendo University Hospital, and the study was conducted in accordance with the principles of the Helsinki Declaration. Written informed consents from all patients enrolled were obtained.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"A.J. Smit is co-founder and shareholder of Diagnoptics Technologies, the company which developed the AGE reader. The other authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"195"}}